Friday, October 15, 2021

Biden admin backs proposal to suspend intellectual property on pandemic vaccines, angering industry


Bucking the pharma industry on the closely watched issue of patent rights for COVID-19 vaccines, the Biden administration came out in favor of a proposal at the World Trade Organization to suspend intellectual property protections for pandemic shots.

In a statement Wednesday, U.S. Trade Representative Katherine Tai said the “extraordinary circumstances” of the pandemic call for “extraordinary measures.” The administration supports intellectual property protections generally, she said, but “in service of ending this pandemic,” it also supports “the waiver of those protections for COVID-19 vaccines.”

The news drew a swift rebuke from Stephen Ubl, head of the top industry lobbying group PhRMA, who called the move an “unprecedented step that will undermine our global response to the pandemic and compromise safety.” The decision “does nothing to address the real challenges to getting more shots in arms, including last-mile distribution and limited availability of raw materials,” he added.

While the pharma industry opposed the move, Oxfam and other groups lauded the decision. In a statement, Public Citizen’s Global Trade Watch director Lori Wallach thanked the president and Tai for “prioritizing saving human lives and livelihoods” in the fight against the pandemic.

RELATED: Facing fresh pricing threats in D.C., pharma spent a record $92M peddling influence during the first quarter

COVID-19 vaccines have been deployed around the world in an impressive fashion in recent months, but while the U.S. now has an excess, India and other countries face dire shortages. The proposal is aimed at allowing local drug manufacturers around the world to produce proven vaccines.

Critics argue it won’t fulfill its intended goal. Since existing COVID-19 vaccine producers have spent countless hours learning and improving their production procedures, critics say the manufacturing should be left to them. The waiver could also worsen raw material shortages, they’ve said.

While the U.S. is certainly an important backer for the proposal, the waiver is not final until the WTO reaches a consensus on the issue.





Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...